Approaches to the targeting of treatment for osteoporosis.
about
The pharmacological management of osteoporosisRetinoid X receptors orchestrate osteoclast differentiation and postnatal bone remodeling.Eldecalcitol: a review of its use in the treatment of osteoporosis.Transforming growth factor Beta family: insight into the role of growth factors in regulation of fracture healing biology and potential clinical applications.Clinical assessment of the 1/3 radius using a new desktop ultrasonic bone densitometer.Prevalence of Fracture Risk Factors in Postmenopausal Women Enrolled in the POSSIBLE US Treatment Cohort.How to decide intervention thresholds based on FRAX in central south Chinese postmenopausal women.Pharmacogenetics of osteoporosis-related bone fractures: moving towards the harmonization and validation of polymorphism diagnostic tools.Relationship between antipsychotic medication, serum prolactin levels and osteoporosis/osteoporotic fractures in patients with schizophrenia: a critical literature review.Involvement of endoplasmic reticulum stress in homocysteine-induced apoptosis of osteoblastic cells.Tcf12, A Member of Basic Helix-Loop-Helix Transcription Factors, Mediates Bone Marrow Mesenchymal Stem Cell Osteogenic Differentiation In Vitro and In Vivo.Increased fracture risk assessed by fracture risk assessment tool in Greek patients with Crohn's disease.Taurine promotes human mesenchymal stem cells to differentiate into osteoblast through the ERK pathway.Synergistic protection of bone vasculature and bone mass by desferrioxamine in osteoporotic mice.
P2860
Q24605290-68BA9F9F-1FF8-490C-8497-5F910CE3312CQ30619787-5D13053A-5012-4D90-AA31-81AB9AA886A4Q34214638-FE13789B-508C-4F8D-8315-DCE6884D96DEQ35076034-9022A633-BCAB-4BA0-BFCC-318F9458E541Q36604877-562C8B50-2BA9-41E5-AF35-B86CE95DADE1Q36766167-31F98C80-E99B-48F8-B09D-5321CF11F174Q37583107-F90A8FB2-91D6-41C5-B9CA-0E6780EB7185Q37791155-89E1EEA1-579A-4C7A-80CD-AC6A548DB8D8Q38778145-EC83E8D7-D615-4110-9132-C270B1C53FFFQ39416923-CF938144-38AE-4FB2-AF8B-A60DBF8C1080Q39441833-073F661B-E089-409E-9C3F-07B3EC0DA9D6Q43457561-97855BF5-0ECF-4129-AF32-57077FA3E7A1Q46285303-747F82CD-1905-4FFD-A524-05505C5CD991Q50122432-C7E27A65-D724-4D7E-BBCA-DC800A2DE1F1
P2860
Approaches to the targeting of treatment for osteoporosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Approaches to the targeting of treatment for osteoporosis.
@en
Approaches to the targeting of treatment for osteoporosis.
@nl
type
label
Approaches to the targeting of treatment for osteoporosis.
@en
Approaches to the targeting of treatment for osteoporosis.
@nl
prefLabel
Approaches to the targeting of treatment for osteoporosis.
@en
Approaches to the targeting of treatment for osteoporosis.
@nl
P2093
P2860
P356
P1476
Approaches to the targeting of treatment for osteoporosis.
@en
P2093
Anders Oden
Eugene V McCloskey
Helena Johansson
John A Kanis
P2860
P2888
P304
P356
10.1038/NRRHEUM.2009.139
P407
P577
2009-08-01T00:00:00Z